Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America

Journal of the International AIDS Society

Volumn 15, Issue 1, 2012, Pages

  Zhou, Jialun ^a   Jaquet, Antoine ^b   Bissagnene, Emmanuel ^c   Musick, Beverly ^d   Wools Kaloustian, Kara ^d   Maxwell, Nicola ^e   Boulle, Andrew ^e   Wehbe, Firas ^f   Masys, Daniel ^f   Iriondo Perez, Jeniffer ^g   Hemingway Foday, Jay ^g   Law, Matthew ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b INSERM   (France)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE TREICHVILLE   (Côte d’Ivoire)

^d INDIANA UNIVERSITY   (United States)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

^f VANDERBILT UNIVERSITY   (United States)

^g RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; HEMOGLOBIN; VIRUS RNA; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AFRICA; ANEMIA; ANTIVIRAL THERAPY; ARTICLE; ASIA; BLOOD TESTIS BARRIER; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COMBINATION ANTIRETROVIRAL THERAPY; DATA BASE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEMODYNAMIC MONITORING; HEMOGLOBIN ANALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SEXUAL BEHAVIOR; SOUTH AND CENTRAL AMERICA; TUBERCULOSIS; ADOLESCENT; AFRICA SOUTH OF THE SAHARA; BLOOD; MIDDLE AGED; PACIFIC ISLANDS; SOUTH AMERICA;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; ANEMIA; ANTI-HIV AGENTS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PACIFIC ISLANDS; RISK FACTORS; SOUTH AMERICA; YOUNG ADULT;

EID: 84862802799     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.1186/1758-2652-15-5     Document Type: Article

References (28)

1. WHO, UNAIDS, UNICEF, Towards universal access: scaling up priority HIV/AIDS interventions in the health sector 2010 Progress report 2010. Geneva
2. WHO, Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach 2010 2009 revision. Geneva
3. Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort. Boulle A, Orrel C, Kaplan R, Van Cutsem G, McNally M, Hilderbrand K, Myer L, Egger M, Coetzee D, Maartens G, Wood R, Antivir Ther 2007 12 5 7537 7560
4. Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database. Zhou J, Paton N, Ditangco R, Chen YM, Kamarulzaman A, Kumarasamy N, Lee CKC, Li PCK, Merati TP, Phanuphak P, Pujari S, Vibhagool A, Zhang F, Chuah J, Frost KF, Cooper DA, Law MG, on behalf of the TREAT Asia HIV Observational Database, HIV Med 2007 8 1 8 16 10.1111/j.1468-1293.2007.00417.x 17305926 (Pubitemid 46117835)
5. Anaemia in HIV infection: clinical impact and evidence-based management strategies. Volberding PA, Levine AM, Dieterich D, Mildvan D, Mitsuyasu R, Saag M, Clin Infect Dis 2004 38 10 1454 1463 10.1086/383031 15156485 (Pubitemid 38668593)
6. Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial. Bussmann H, Wester CW, Thomas A, Novitsky V, Okezie R, Muzenda T, Gaolathe T, Ndwapi N, Mawoko N, Widenfelt E, Moyo S, Musonda R, Mine M, Makhema J, Moffat H, Essex M, DeGruttola V, Marlink R, Journal of Acquired Immune Deficiency Syndromes 2009 51 1 37 46 10.1097/QAI.0b013e31819ff102 19282782
7. Anaemia in a rural Ugandan HIV cohort: prevalence at enrolment, incidence, diagnosis and associated factors. Mugisha JO, Shafer LA, Van der Paal L, Mayanja BN, Eotu H, Hughes P, Whitworth JAG, Grosskurth H, Tropical Medicine & International Health 2008 13 6 788 794 10.1111/j.1365-3156.2008.02069.x 22294824 (Pubitemid 351678637)
8. Department of Health and Human Services (DHHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), RFA-AI-05-014: International Epidemiologic Databases to Evaluate AIDS http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-05-014.html 2005 (Oct 2009)
9. Tobacco use and its determinants in HIV-infected patients on antiretroviral therapy in West African countries. Jaquet A, Ekouevi DK, Aboubakrine M, Bashi J, Messou E, Maiga M, Traore H, Zannou M, Guehi C, Ba-Gomis F, Minga A, Allou G, Eholie S, Dabis F, Bissagnene E, Sasco A, Int J Tuberc Lung Dis 2009 13 11 1433 1439 19861019
10. Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaboration. Cornell M, Technau K, Fairall L, Wood R, Moultrie H, van Cutsem G, Giddy J, Mohapi L, Eley B, MacPhail P, Prozesky H, Rabie H, Davies M, Maxwell N, Boulle A, for the Internationalepidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration, S Afr Med J 2009 99 9 653 660 20073292
11. The impact of the President's Emergency Plan for AIDS Relief on expansion of HIV care services for adult patients in western Kenya. Wools-Kaloustian K, Kimaiyo S, Musick B, Sidle J, Siika A, Nyandiko W, Einterz R, Tierney W, Yiannoutsos CT, AIDS 2009 23 2 195 201 10.1097/QAD.0b013e32831cc0e6 19098489
12. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Muller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M, The Lancet Infectious Diseases 2010 10 4 251 261 10.1016/S1473-3099(10)70026-8 20334848
13. The TREAT Asia HIV Observational Database: Baseline and Retrospective Data. Zhou J, Kumarasamy N, Ditangco R, Kamarulzaman A, Lee CK, Li PC, Paton NI, Phanuphak P, Pujari S, Vibhagool A, Wong WW, Zhang F, Chuah J, Frost KF, Cooper DA, Law MG, J Acquir Immune Defic Syndr 2005 38 2 174 179 10.1097/01.qai. 0000145351.96815.d5 15671802 (Pubitemid 40189324)
14. Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. McGowan CC, Cahn P, Gotuzzo E, Padgett D, Pape JW, Wolff M, Schechter M, Masys DR, Int J Epidemiol 2007 36 5 969 976 10.1093/ije/dym073 17846055 (Pubitemid 350018541)
15. NIH DAIDS, Table for Grading the Severity of Adult and Pediatric Adverse Events 2009 http://rcc.tech-res.com/safetyandpharmacovigilance/ Version 1.0 2009 October
16. Changes in hematologic parameters and efficacy of thymidine analogue-based, highly active antiretroviral therapy: a meta-analysis of six prospective, randomized, comparative studies. Moyle G, Sawyer W, Law M, Amin J, Hill A, Clin Ther 2004 26 1 92 97 10.1016/S0149-2918(04)90009-4 14996521 (Pubitemid 38241526)
17. Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial. Ssali F, Stöhr W, Munderi P, Reid A, Walker AS, Gibb DM, Mugyenyi P, Kityo C, Grosskurth H, Hakim J, Byakwaga H, Katabira E, Darbyshire JH, Gilks CF, DART Trial Team, Antivir Ther 2006 11 6 741 749 17310818 (Pubitemid 44497169)
18. WHO, Scaling up antiretroviral therapy in resource-limited settings: guidelines for a public health approach. Geneva 2002
19. WHO, Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach 2004 2003 revision. Geneva
20. WHO, Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach 2006 2006 revision. Geneva
21. WHO, Rapid advice: antiretroviral therapy for HIV infection in adults and adolescents 2009 http://www.who.int/hiv/pub/arv/rapid-advice-art.pdf
22. Department of Health and Human Services (DHHS), Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents 2009 http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf
23. British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. Gazzard BG, Anderson J, Babiker A, Boffito M, Brook G, Brough G, Churchill D, Cromarty B, Das S, Fisher M, Freedman A, Geretti AM, Johnson M, Khoo S, Leen C, Nair D, Peters B, Phillips A, Pillay D, Pozniak A, Walsh J, Wilkins E, Williams I, Williams M, Youle M, BHIVA Treatment Guidelines Writing Group, HIV Med 2008 9 8 563 608 10.1111/j.1468-1293.2008.00636.x 18826546
24. Monitoring the toxicity of antiretroviral therapy in resource limited settings: a prospective clinical trial cohort in Thailand. Nuesch R, Srasuebkul P, Ananworanich J, Ruxrungtham K, Phanuphak P, Duncombe C, J Antimicrob Chemother 2006 58 3 637 644 10.1093/jac/dkl313 16895939 (Pubitemid 44288131)
25. NIH CDC HIVMA/IDSA, Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents 2009 http://aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem= Guidelines&Search=Off&GuidelineID=211&ClassID=4%5D
26. Prior antiretroviral therapy experience protects against zidovudine-related anaemia. Huffam SE, Srasuebkul P, Zhou J, Calmy A, Saphonn V, Kaldor JM, Ditangco R, TREAT Asia HIV Observational Database, HIV Med 2007 8 7 465 471 10.1111/j.1468-1293.2007.00498.x 17760739 (Pubitemid 47335269)
27. Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon. AIDS research and human retroviruses. Laurent C, Bourgeois A, Mpoudi-Ngolé E, Ciaffi L, Kouanfack C, Mougnutou R, Nkoué N, Calmy A, Koulla-Shiro S, Delaporte E, AIDS Res Hum Retroviruses 2008 24 3 393 399 10.1089/aid.2007.0219 18327976 (Pubitemid 351457754)
28. Evaluation of a systematic substitution of zidovudine for stavudine-based HAART in a program setting in rural Cambodia. Isaakidis P, Raguenaud ME, Phe T, Khim SA, Kuoch S, Khem S, Reid T, Arnold L, J Acquir Immune Defic Syndr 2008 49 1 48 54 10.1097/QAI.0b013e31817bec19 18667931